Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Carcinoma, Hepatocellular 44Neoplasm Metastasis 19Liver Neoplasms 18Colorectal Neoplasms 15Cholangiocarcinoma 11Pancreatic Neoplasms 9Lung Neoplasms 9Colonic Neoplasms 9Breast Neoplasms 8Carcinoma, Renal Cell 7Carcinoma, Non-Small-Cell Lung 7Barrett Esophagus 7Thyroid Nodule 6Recurrence 6Rectal Neoplasms 6Thyroid Neoplasms 5Pain 4Neoplasms 4Kidney Neoplasms 4Esophageal Neoplasms 4Thyroid Cancer, Papillary 3Prostatic Neoplasms 3Leiomyoma 3Biliary Tract Neoplasms 3Bile Duct Neoplasms 3Agnosia 3Thyroid Diseases 2Hyperaldosteronism 2Hepatitis B 2Gallbladder Neoplasms 2

Interventions

Paclitaxel 328Carboplatin 323Bevacizumab 171Gemcitabine 106liposomal doxorubicin 104pembrolizumab 101Cyclophosphamide 96Topotecan 94olaparib 92Cisplatin 92niraparib 69Docetaxel 57Taxes 52Doxorubicin 51Drug Therapy 45fludarabine 40Filgrastim 39Nivolumab 37Magnetic Resonance Spectroscopy 34Surveys and Questionnaires 33Specimen Handling 33Etoposide 32Hyperthermic Intraperitoneal Chemotherapy 31Blood Specimen Collection 29Immunoglobulin G 27Disulfides 27Peripheral Blood Stem Cell Transplantation 26Cytoreduction Surgical Procedures 25Albumin-Bound Paclitaxel 25durvalumab 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ovarian Neoplasms × Radiofrequency Ablation × Clear all
NCT02487693 2016-02-23

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Ovarian Carcinoma

The First People's Hospital of Changzhou

Phase 2 Active not recruiting
50 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡